Eupraxia Pharmaceuticals Inc (EPRX) News

Form 425 - Prospectuses and communications, business combinations

Form 8-K - Current report

Form S-4/A - Registration of securities, business combinations: [Amend]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form S-4/A - Registration of securities, business combinations: [Amend]

Golden Arrow Merger Corp. Announces Cancellation of Special Meeting

NEW YORK, NY, Dec. 14, 2022 (GLOBE NEWSWIRE) -- Golden Arrow Merger Corp. (the “Company”) (NYSE: GAMCU, GAMC, GAMCW), announced today its...

Stemming from SEC Guidance Concerning Accounting Treatment of Warrants, Golden Arrow Merger Corp. Announces Receipt of Nasdaq...

New York, NY, June 04, 2021 (GLOBE NEWSWIRE) -- Golden Arrow Merger Corp. (the “Company”)  today announced that on May 28, 2021 it received a...

Golden Arrow Merger Corp. Announces Full Exercise and Closing of the Underwriters’ Over-Allotment Option in Connection with...

NEW YORK, NY, May 06, 2021 (GLOBE NEWSWIRE) -- Golden Arrow Merger Corp. (the “Company”) announced today that the underwriters of its...

Golden Arrow Merger Corp. Announces Closing of $250 Million Initial Public Offering

New York, NY, March 19, 2021 (GLOBE NEWSWIRE) -- Golden Arrow Merger Corp. (the “Company”) announced today the closing of its initial public...

Golden Arrow Merger Corp. Announces Pricing of $250 Million Initial Public Offering

New York, NY, March 16, 2021 (GLOBE NEWSWIRE) -- Golden Arrow Merger Corp. (the “Company”) announced today that it priced its initial public...